Delivery Order SPE2DB22D3004-SPE2DB25FPT17
Award Date
2/28/25
Potential Completion Date
3/3/25
Potential Value
$3.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,951.32 firm fixed-price contract is for the delivery of valganciclovir hydrochloride 50 mg/mL oral solution. The ultimate completion date is November 14, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $36,657.24, is for the delivery of valganciclovir hydrochloride oral solution, a medication used to treat certain viral infections. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,902.03 firm-fixed-price delivery order is for the supply of 88 ml of valganciclovir hydrochloride 50 mg/ml, a medication used to treat cytomegalovirus infections. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 60 count bottles of 450 mg valganciclovir tablets. This $2,050.03 award has an ultimate completion date of April 12, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp, a for-profit organization, serves as the prime contractor and provides a wide range of pharmaceutical products and medical...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FPH63) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,055.37 firm fixed-price contract is for the supply of valganciclovir HCL 50 mg/ml, an antiviral medication, to support military healthcare programs. The contract is not designated as a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,191.37, is for the delivery of valganciclovir hydrochloride, a pharmaceutical product used in the treatment of certain medical conditions. The contract has a period of performance through May 7, 2024, and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,191.08 firm fixed-price delivery order is for the supply of 4563033480 - Valganciclovir HCL 50 MG/ML 88ML, with a period of performance ending on December 8, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,907.97, is for the delivery of Valganciclovir 450 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,662.65 firm fixed-price contract is for the delivery of 60 tablets of the medication valganciclovir 450 mg. The contract has a performance period through January 5, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and there is no...